English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Dear Editor, We want to thank Huo and Liu [1] for their great interest in our paper [2] and for sharing their data. Indeed, thrombocytosis was repeatedly associated with a worse prognosis in patients with various cancer entities [3, 4]. Prophylactic treatment with acetylsalicylic acid does not only reduce the risk of cancer development [5] but may also reduce the risk of distant metastasis formation [6]. Following the findings of Huo and Liu [1], we performed a pooled analysis of our two cohorts comparing the overall survival (OS) of patients with thrombocytopenia (platelets < 150 g/L), normal platelet count (150–350 g/L), and thrombocytosis (≥350 g/L). As shown in Figure 1, OS was significantly reduced with Received: October 7, 2019 Accepted: October 9, 2019 Published online: December 11, 2019

Reply to the Letter to the Editor Entitled “Too Many versus Too Few Platelets in Patients with Hepatocellular Carcinoma: Good or Bad?”